GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

Casey’s work was accepted into CBM for an active learning based AI model that can guide clinical pace-mapping procedure to intervention targets in real time for ventricular arrhythmia of the heart.